PARTNERSHIP IN STRUCTURAL HEART CARE AT EVERY STAGE OF LIFE
The Abbott portfolio of structural heart treatment options has expanded significantly in recent years. We feature products to treat the broad spectrum of structural heart disease (SHD)—encompassing both congenital heart defects and acquired conditions, such as valvular heart disease.
Because SHD affects millions of lives around the world,1 Abbott’s new technologies—as well as long-established, industry-leading therapies—are vital to restore patients’ health.
Our expanding SHD portfolio provide solutions with a range of therapies:
- Transcatheter valvular solutions
- Surgical valvular solutions
- Structural heart occluders
Abbott’s transcatheter valvular solutions are particularly valuable for certain high-risk patients who may otherwise be contraindicated for surgical valve repair or replacement.
For a broad range of SHD conditions, Abbott enables physicians to offer their patients optimal treatments—and improved quality of life.